Mortality risk in multivessel CAD: contemporary assessment of the SYNTAX score
- 22 September 2026
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal - Quality of Care and Clinical Outcomes
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Validated 1-year mortality prediction in patients with three-vessel disease undergoing contemporary percutaneous coronary intervention: insights from the Multivessel TALENT trialEuropean Heart Journal - Quality of Care and Clinical Outcomes, 2026
- 2024 ESC Guidelines for the management of chronic coronary syndromesEuropean Heart Journal, 2024
- A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trialEuroIntervention, 2020
- Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trialEuroIntervention, 2019
- Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score IIThe Lancet, 2013
- Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX scoreEuropean Heart Journal, 2012
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery DiseaseNew England Journal of Medicine, 2009